TY - JOUR
T1 - The Oncofertility Consortium-addressing fertility in young people with cancer
AU - Woodruff, Teresa K.
N1 - Funding Information:
■ The Oncofertility Consortium is a confederation of partners funded by an NIH Roadmap grant that is advancing fertility preservation options for young cancer patients
Funding Information:
The Oncofertility Consortium is funded by a number of NIH Interdisciplinary Research Consortium grants: NIDCR 8UL1DE019587, NICHD 1RL1HD058293, NICHD 1RL1HD058294, NICHD 5RL1HD058295, NICHD 5RL1HD058296, NIBIB 5PL1EB008542, NCI 1PL1CA133835, NCI 5RL5CA133836, NCI 5TL1CA133837/5RL9CA133838, NCI 1KL1CA133839. The original in vitro follicle maturation studies were funded by a Specialized Cooperative Centers Program in Infertility Research (SCCPIR) NIH/NICHD U54HD041857. The author is grateful for the comments of an interdisciplinary team of readers (listed alphabetically: Lisa Campo‑ Engelstein, Marla Clayman, Francesca Duncan, Shauna Gardino, Marybeth Gerrity, Sarah Rodriguez, Lonnie Shea, Candace Tingen and Min Xu). The author also thanks Stacey Tobin for assistance with language editing.
PY - 2010/8
Y1 - 2010/8
N2 - The number of young cancer survivors is increasing owing to advances in cancer therapeutics, but many face infertility as a result of their treatment. Technologies that already exist for cancer patients concerned about their future fertility include sperm banking for men and hormonal intervention followed by in vitro fertilization and embryo cryopreservation for women. However, logistical barriers to timely patient referral and coordination of care between specialties can limit patient access to all the available options. Moreover, there are few alternatives for young women and girls who cannot delay their cancer treatment, or who are unable to undergo hormonal intervention. The Oncofertility Consortium is a network of researchers, physicians and scholars who are advancing fertility preservation options for young cancer patients. Research into the societal, ethical, and legal implications is also an important part of the work performed by the Oncofertility Consortium, which is providing new perspectives on patient decision-making about how to access these emerging reproductive technologies. Experts in the fields of oncology, reproductive medicine, the social sciences, law, education, and the humanities are working together to develop next-generation reproductive interventions and promote communication between scholars, clinicians, patients, and the public to ensure that young cancer patients are equipped with the most appropriate information and options for having a family in the future.
AB - The number of young cancer survivors is increasing owing to advances in cancer therapeutics, but many face infertility as a result of their treatment. Technologies that already exist for cancer patients concerned about their future fertility include sperm banking for men and hormonal intervention followed by in vitro fertilization and embryo cryopreservation for women. However, logistical barriers to timely patient referral and coordination of care between specialties can limit patient access to all the available options. Moreover, there are few alternatives for young women and girls who cannot delay their cancer treatment, or who are unable to undergo hormonal intervention. The Oncofertility Consortium is a network of researchers, physicians and scholars who are advancing fertility preservation options for young cancer patients. Research into the societal, ethical, and legal implications is also an important part of the work performed by the Oncofertility Consortium, which is providing new perspectives on patient decision-making about how to access these emerging reproductive technologies. Experts in the fields of oncology, reproductive medicine, the social sciences, law, education, and the humanities are working together to develop next-generation reproductive interventions and promote communication between scholars, clinicians, patients, and the public to ensure that young cancer patients are equipped with the most appropriate information and options for having a family in the future.
UR - http://www.scopus.com/inward/record.url?scp=77955174670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955174670&partnerID=8YFLogxK
U2 - 10.1038/nrclinonc.2010.81
DO - 10.1038/nrclinonc.2010.81
M3 - Review article
C2 - 20498666
AN - SCOPUS:77955174670
VL - 7
SP - 466
EP - 475
JO - Nature Reviews Clinical Oncology
JF - Nature Reviews Clinical Oncology
SN - 1759-4774
IS - 8
ER -